Noramco™
Chris Roman has extensive experience in supply chain management, business planning, new product introduction, process engineering, and technical support. With a strong background in chemical engineering, Chris has successfully managed various roles within Noramco™, leading teams, optimizing production processes, implementing new products, and driving continuous improvement initiatives. With an MBA in Operations Management, Chris combines technical expertise with strategic business acumen to deliver results and drive operational excellence.
This person is not in any teams
Noramco™
Noramco, headquartered in Wilmington, Delaware, is a global leader in the production of controlled substances for the pharmaceutical industry, for medicines used to treat attention deficit hyperactivity disorder, pain, addiction, and for abuse-deterrent formulations. We realize our success through a keen focus on commercial and operational excellence as well as continuing strategic growth. Our global footprint includes Athens, GA, Wilmington, DE and Neuhausen, Switzerland. Specialists in controlled substance development and manufacturing, Noramco is a partner to the pharmaceutical industry: – Focusing on high-purity controlled substances – Leveraging intellectual property to devise the most efficient routes to APIs – Providing analytical data, chemical and physical properties, stability studies and regulatory assistance – Formulation friendly particle size grades and extended technical packages – Delivering DEA-compliant security and production capacity, from kilos to multi-ton supply – Supporting world-class supply security of controlled-substances, from schedule I to schedule III